Comparison between tenofovir alafenamide and entecavir in the efficacy and safety for chronic hepatitis B patients treatment.
Phase of Trial: Phase II
Latest Information Update: 14 Sep 2017
Price : $35 *
At a glance
- Drugs Entecavir (Primary) ; Tenofovir alafenamide (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 12 Sep 2017 Status changed from not yet recruiting to recruiting.
- 04 Apr 2017 New trial record